Kudo M - Search Results

1

CheckMate 040 cohort 5: A phase I/II study of nivolumab in patients with advanced hepatocellular carcinoma and Child-Pugh B cirrhosis.

Kudo M, Matilla A, Santoro A, Melero I, Gracián AC, Acosta-Rivera M, Choo SP, El-Khoueiry AB, Kuromatsu R, El-Rayes B, Numata K, Itoh Y, Di Costanzo F, Crysler O, Reig M, Shen Y, Neely J, Tschaika M, Wisniewski T, Sangro B. Kudo M, et al. J Hepatol. 2021 Sep;75(3):600-609. doi: 10.1016/j.jhep.2021.04.047. Epub 2021 May 26. J Hepatol. 2021. PMID: 34051329 Free article.

2

Validation of a new prognostic staging system for hepatocellular carcinoma: the JIS score compared with the CLIP score.

Kudo M, Chung H, Haji S, Osaki Y, Oka H, Seki T, Kasugai H, Sasaki Y, Matsunaga T. Kudo M, et al. Hepatology. 2004 Dec;40(6):1396-405. doi: 10.1002/hep.20486. Hepatology. 2004. PMID: 15565571

3

Early detection and curative treatment of early-stage hepatocellular carcinoma.

Kudo M. Kudo M. Clin Gastroenterol Hepatol. 2005 Oct;3(10 Suppl 2):S144-8. doi: 10.1016/s1542-3565(05)00712-3. Clin Gastroenterol Hepatol. 2005. PMID: 16234064 Review.

4

Antibody to hepatitis B core antigen and risk for hepatitis C-related hepatocellular carcinoma: a prospective study.

Ikeda K, Marusawa H, Osaki Y, Nakamura T, Kitajima N, Yamashita Y, Kudo M, Sato T, Chiba T. Ikeda K, et al. Among authors: kudo m. Ann Intern Med. 2007 May 1;146(9):649-56. doi: 10.7326/0003-4819-146-9-200705010-00008. Ann Intern Med. 2007. PMID: 17470833

5

Comparison of three current staging systems for hepatocellular carcinoma: Japan integrated staging score, new Barcelona Clinic Liver Cancer staging classification, and Tokyo score.

Chung H, Kudo M, Takahashi S, Hagiwara S, Sakaguchi Y, Inoue T, Minami Y, Ueshima K, Fukunaga T, Matsunaga T. Chung H, et al. Among authors: kudo m. J Gastroenterol Hepatol. 2008 Mar;23(3):445-52. doi: 10.1111/j.1440-1746.2007.05075.x. Epub 2007 Aug 6. J Gastroenterol Hepatol. 2008. PMID: 17683486

6

Outcomes of nontransplant potentially curative therapy for early-stage hepatocellular carcinoma in Child-Pugh stage A cirrhosis is comparable with liver transplantation.

Takahashi S, Kudo M, Chung H, Inoue T, Nagashima M, Kitai S, Tatsumi C, Minami Y, Ueshima K, Fukunaga T, Haji S. Takahashi S, et al. Among authors: kudo m. Dig Dis. 2007;25(4):303-9. doi: 10.1159/000106909. Dig Dis. 2007. PMID: 17960064

7

Prognostic value of pretreatment levels of tumor markers for hepatocellular carcinoma on survival after curative treatment of patients with HCC.

Toyoda H, Kumada T, Kaneoka Y, Osaki Y, Kimura T, Arimoto A, Oka H, Yamazaki O, Manabe T, Urano F, Chung H, Kudo M, Matsunaga T. Toyoda H, et al. Among authors: kudo m. J Hepatol. 2008 Aug;49(2):223-32. doi: 10.1016/j.jhep.2008.04.013. Epub 2008 May 23. J Hepatol. 2008. PMID: 18571271

8

Surgical resection vs. percutaneous ablation for hepatocellular carcinoma: a preliminary report of the Japanese nationwide survey.

Hasegawa K, Makuuchi M, Takayama T, Kokudo N, Arii S, Okazaki M, Okita K, Omata M, Kudo M, Kojiro M, Nakanuma Y, Takayasu K, Monden M, Matsuyama Y, Ikai I. Hasegawa K, et al. Among authors: kudo m. J Hepatol. 2008 Oct;49(4):589-94. doi: 10.1016/j.jhep.2008.05.018. Epub 2008 Jun 12. J Hepatol. 2008. PMID: 18620773

9

Hepatocellular carcinoma 2009 and beyond: from the surveillance to molecular targeted therapy.

Kudo M. Kudo M. Oncology. 2008;75 Suppl 1:1-12. doi: 10.1159/000181865. Epub 2008 Dec 17. Oncology. 2008. PMID: 19092266 Review.

10

Impact of interferon therapy after curative treatment of hepatocellular carcinoma.

Kudo M. Kudo M. Oncology. 2008;75 Suppl 1:30-41. doi: 10.1159/000173422. Epub 2008 Dec 17. Oncology. 2008. PMID: 19092270

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,541 results

Search Page

Filters